NPI: 1568437978 · SAN DIEGO, CA 92114 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 02/20/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 02/20/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| DVA RENAL HEALTHCARE INC | SELLS | AZ | $7.17M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 24,791 | $2.51M |
| 2019 | 25,013 | $2.33M |
| 2020 | 23,342 | $1.52M |
| 2021 | 22,090 | $1.52M |
| 2022 | 21,818 | $1.73M |
| 2023 | 19,668 | $1.93M |
| 2024 | 17,401 | $2.14M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 65,985 | 5,345 | $13.13M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 36,062 | 2,677 | $224K |
| A4657 | Syringe, with or without needle, each | 4,878 | 2,219 | $88K |
| J1756 | Injection, iron sucrose, 1 mg | 10,822 | 2,989 | $65K |
| J1270 | Injection, doxercalciferol, 1 mcg | 17,140 | 1,506 | $60K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 1,769 | 1,174 | $41K |
| 90945 | 294 | 12 | $33K | |
| 0250 | 6,949 | 490 | $23K | |
| 83970 | 1,735 | 1,551 | $4K | |
| 82728 | 1,214 | 1,142 | $1K | |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 54 | 44 | $987.80 |
| 82108 | 490 | 468 | $849.50 | |
| 82746 | 526 | 505 | $746.65 | |
| 83540 | 1,299 | 1,208 | $590.88 | |
| 90662 | 94 | 92 | $532.28 | |
| 83550 | 1,109 | 1,027 | $444.23 | |
| 85041 | 1,593 | 1,504 | $440.73 | |
| 85048 | 1,639 | 1,482 | $390.53 | |
| G0008 | Administration of influenza virus vaccine | 56 | 55 | $302.99 |
| 90674 | 105 | 105 | $218.32 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 297 | 231 | $192.12 |
| 90661 | 13 | 13 | $41.31 |